Broad Human Immunodeficiency Virus (HIV)-specific T Cell Responses to Conserved HIV Proteins in HIV-seronegative Women Highly Exposed to a Single HIV-infected Partner
Overview
Authors
Affiliations
Eighteen highly exposed but persistently seronegative (HEPS) women (HW) and their human immunodeficiency virus (HIV) type 1-seropositive male partners were studied for HIV-specific T cells and other host factors. Circulating HIV-specific T cells were measured by interferon-gamma enzyme-linked immunospot assays, using recombinant vaccinia virus vectors expressing HIV proteins. Nine (50%) of the HW and all HIV-seropositive persons had HIV-specific T cell responses. Only 2 (22%) of the HEPS responders recognized Env, compared with 94% of HIV-seropositive persons. A high percentage (75%) of the HW with HIV-specific T cell responses reported recent HIV exposure. Remarkably, however, long-lived HIV-specific T cells were detected in 2 HW who had an extended period (>3.9 years) of no HIV exposure. These findings have important implications for HIV vaccine design.
Can T Cells Abort SARS-CoV-2 and Other Viral Infections?.
Swadling L, Maini M Int J Mol Sci. 2023; 24(5).
PMID: 36901802 PMC: 10002440. DOI: 10.3390/ijms24054371.
Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2.
Swadling L, Diniz M, Schmidt N, Amin O, Chandran A, Shaw E Nature. 2021; 601(7891):110-117.
PMID: 34758478 PMC: 8732273. DOI: 10.1038/s41586-021-04186-8.
Michalak T Front Immunol. 2020; 11:853.
PMID: 32536912 PMC: 7267019. DOI: 10.3389/fimmu.2020.00853.
Mulrooney-Cousins P, Michalak T J Clin Transl Hepatol. 2015; 3(3):211-9.
PMID: 26623268 PMC: 4663203. DOI: 10.14218/JCTH.2015.00020.
HIV competition dynamics over sexual networks: first comer advantage conserves founder effects.
Ferdinandy B, Mones E, Vicsek T, Muller V PLoS Comput Biol. 2015; 11(2):e1004093.
PMID: 25654450 PMC: 4318579. DOI: 10.1371/journal.pcbi.1004093.